• Теги
    • избранные теги
    • Компании2083
      • Показать ещё
      • Показать ещё
      Международные организации49
      • Показать ещё
      Страны / Регионы551
      • Показать ещё
      • Показать ещё
      • Показать ещё
      • Показать ещё
Выбор редакции
29 мая, 15:23

Kite Pharma Cancer Drug BLA Gets Priority Review Status

Kite Pharma, Inc. (KITE) announced that its biologics license application (BLA) for its experimental CAR-T therapy, axicabtagene ciloleucel has been accepted for priority review by the FDA.

Выбор редакции
28 мая, 22:51

Наемники «Джебхат ан-Нусры» начали принимать пожертвования в биткоинах

Боевики из исламской ЧВК Malhama Tactical открыли сбор средств на дальнейшую деятельность

28 мая, 13:51

UPDATE 1-Deadly brain infection in German MS patient prompts Roche investigation

A person in Germany treated with Roche Holding AG’s new multiple sclerosis drug Ocrevus has been diagnosed with an often-deadly brain infection after switching from another medication earlier this year, the Swiss drugmaker said on Wednesday. Roche said it was investigating a case of Progressive Multifocal Leukoencephalopathy (PML) in a patient previously being treated for three years with Biogen Inc's Tysabri and who had received a single dose of Ocrevus in April. Roche is trying to determine the source of the illness but MS drugs that suppress the immune system can increase the risk of serious infections.

26 мая, 17:26

Roche (RHHBY) Presents Positive Data on IPF Drug Esbriet

Roche Holding AG (RHHBY) announced new retrospective data analyses for idiopathic pulmonary fibrosis (IPF) drug, Esbriet.

26 мая, 16:48

Puma Soaring After Neratinib FDA Panel Win, Time to Buy?

Shares of Puma Biotechnology, Inc. (PBYI) have risen 35% since it announced that an FDA advisory committee recommended the approval of its lead pipeline candidate, neratinib for the treatment of some breast cancers.

26 мая, 16:36

Pfizer's Epogen Biosimilar Gets Positive FDA Committee Vote

Pfizer, Inc. (PFE) announced that an FDA advisory committee has recommended approval of its biosimilar version of ESA Epogen and Procrit.

26 мая, 16:31

Celldex's Immuno-Oncology Pipeline Continues to Impress

On May 25, we issued an updated research report on Hampton, NJ-based Celldex Therapeutics, Inc. (CLDX).

26 мая, 10:53

Biogen (BIIB) Down 9.5% Since Earnings Report: Can It Rebound?

BIIB reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

25 мая, 16:16

Biogen's Fampyra Conditional Approval Converted to Standard

Biogen Inc. (BIIB) announced that the conditional marketing authorization for its drug Fampyra for improvement of walking in multiple sclerosis (MS) patients in the EU has been converted to a standard marketing approval.

25 мая, 14:43

Alnylam Pharmaceuticals (ALNY) Progressing Well on Pipeline

We issued an updated research report on Alnylam Pharmaceuticals, Inc. (ALNY) on May 23, 2017.

Выбор редакции
24 мая, 00:23

BioLineRx Makes Regulatory Submission for Trial of BL-8040

BioLineRx Ltd. (BLRX) announced that it has submitted a regulatory filing required to start a phase Ib study for BL-8040 in combination with Roche Group's (RHHBY) Tecentriq (atezolizumab).

23 мая, 23:41

Roche's Arthritis Drug Gets FDA Nod for Label Expansion

Roche Holdings AG (RHHBY) announced that the FDA has approved Actemra subcutaneous injection for the treatment of giant cell arteritis (GCA).

23 мая, 17:25

Sanofi/Regeneron's Kevzara Gets FDA Approval for Arthritis

Sanofi (SNY) and partner Regeneron Pharmaceuticals, Inc. (REGN) announced that the FDA has approved their pipeline candidate sarilumab to be marketed under the trade name of Kevzara.

23 мая, 07:00

Сирия новости 23 мая 07.00: САА отбила у ИГ сахарную фабрику в Алеппо, в Хомсе ликвидировали 20 боевиков

Армия правительства Сирии отбила у террористов «Исламского государства» сахарную фабрику и деревню Рас аль-Айн в Алеппо, в Хомсе ликвидированы как минимум 20 боевиков ИГ.

Выбор редакции
22 мая, 15:58

Clovis' (CLVS) PARP Inhibtor Shows Promise, Risks Remain

On May 19, we issued an updated research report on Boulder, CO based Clovis Oncology, Inc. (CLVS).

Выбор редакции
19 мая, 16:17

Merck KGaA (MKGAF) Q1 Earnings Fall Y/Y, Revenues Increase

Merck KGaA (MKGAF) reported first-quarter 2017 earnings of $1.28 per American Depositary Share, 14.7% lower than the year-ago figure of $1.50.

19 мая, 14:43

Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More

This week, industry bellwether J&J (JNJ) provided a look at its pharma pipeline while Shire was up on HAE data.